Data Integrity and Form 483 or Warning Letters

April 28, 2014 / Marc Sanchez /

Data integrity is an essential component of both clinical and nonclinical research conducted under the supervision of the Food and Drug Administration.

Share this:
Posted in , and tagged with , , , , , , , , , , , , , , , , , , , , , , , , , ,
Marc Sanchez

Marc Sanchez

Marc is dedicated to helping his clients navigate the complex world of FDA and USDA legislation. He represents FDA-regulated companies in the food, dietary supplement, beverage, cosmetic, medical device, and drug industries.

Marc is the author of two textbooks and a lecturer at Northeastern University. He is a member of the Washington State Bar Association and the D.C. Bar Association.

Leave a Comment

You must be logged in to post a comment.

Categories

Are you in trouble with the FDA?

Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation right now.

Expert knowledge of FDA regulations that helps you strategically grow your business

Book A Free Consultation